Multimorbidities in COPD are Associated With Increased Exacerbations and Health Care Resource Utilization in Real-World Patients from a U.S. Database.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2024-09-27 DOI:10.15326/jcopdf.2024.0515
Jamuna K Krishnan, Fernando J Martinez, Pablo Altman, Ver Luanni F Bilano, Edward Khokhlovich, Raymond Przybysz, Helene Karcher, Matthias Schoenberger
{"title":"Multimorbidities in COPD are Associated With Increased Exacerbations and Health Care Resource Utilization in Real-World Patients from a U.S. Database.","authors":"Jamuna K Krishnan, Fernando J Martinez, Pablo Altman, Ver Luanni F Bilano, Edward Khokhlovich, Raymond Przybysz, Helene Karcher, Matthias Schoenberger","doi":"10.15326/jcopdf.2024.0515","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with chronic obstructive pulmonary disease (COPD) often develop other morbidities, suggesting a systemic component to this disease. This retrospective noninterventional cohort study investigated relationships between multimorbidities in COPD and their impact on COPD exacerbations and COPD-related health care resource utilization (HCRU) using real-world evidence from Optum's de-identified Clinformatics® Data Mart Database.</p><p><strong>Methods: </strong>Demographic and clinical characteristics were assessed. Overall comorbidity burden and proportion of individuals with gastroesophageal reflux disease (GERD), diabetes, or osteoporosis/osteopenia were compared in age-matched COPD versus non-COPD cohorts using descriptive statistics. COPD exacerbations and COPD-related HCRU (hospitalizations and emergency department visits) were compared between age-matched cohorts of COPD patients with and without specific common morbidities (GERD, diabetes, and osteoporosis/osteopenia). Additional weight-matching was performed for matched cohorts of COPD patients with and without diabetes, and with and without osteoporosis/osteopenia. The follow-up period was 5 years.</p><p><strong>Results: </strong>Age-matched cohorts with and without COPD each comprised 158,106 patients. Morbidities were more common in the COPD cohort than the cohort without COPD (GERD: 44.9% versus 27.8%; diabetes: 40.8% versus 31.1%; osteoporosis/osteopenia: 18.8% versus 14.1%, respectively). Compared with matched cohorts with COPD only, cohorts of COPD patients with either GERD, diabetes, or osteoporosis/osteopenia experienced increased risk of severe exacerbations (odds ratio [OR]=1.819, OR=1.119, and OR=1.373, respectively), moderate exacerbations (OR=1.699, OR=1.102, and OR=1.322, respectively), or any exacerbations (OR=1.848, OR=1.099, and OR=1.384, respectively, <i>p</i><0.001 for all comparisons) and increased risk of COPD-related HCRU (emergency department visits: OR=1.983, OR=1.098, and OR=1.343, respectively; hospitalization visits: OR=2.222, OR=1.26, and OR=1.368, respectively; <i>p</i><0.001 for all comparisons).</p><p><strong>Conclusion: </strong>These real-world data confirm that GERD, diabetes, and osteoporosis are common morbidities in patients with COPD and, moreover, that they affect frequency of exacerbation and HCRU. Determining and addressing the mechanisms behind the systemic effects of COPD may be beneficial for COPD patients and may also help reduce COPD exacerbations.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11548965/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15326/jcopdf.2024.0515","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Patients with chronic obstructive pulmonary disease (COPD) often develop other morbidities, suggesting a systemic component to this disease. This retrospective noninterventional cohort study investigated relationships between multimorbidities in COPD and their impact on COPD exacerbations and COPD-related health care resource utilization (HCRU) using real-world evidence from Optum's de-identified Clinformatics® Data Mart Database.

Methods: Demographic and clinical characteristics were assessed. Overall comorbidity burden and proportion of individuals with gastroesophageal reflux disease (GERD), diabetes, or osteoporosis/osteopenia were compared in age-matched COPD versus non-COPD cohorts using descriptive statistics. COPD exacerbations and COPD-related HCRU (hospitalizations and emergency department visits) were compared between age-matched cohorts of COPD patients with and without specific common morbidities (GERD, diabetes, and osteoporosis/osteopenia). Additional weight-matching was performed for matched cohorts of COPD patients with and without diabetes, and with and without osteoporosis/osteopenia. The follow-up period was 5 years.

Results: Age-matched cohorts with and without COPD each comprised 158,106 patients. Morbidities were more common in the COPD cohort than the cohort without COPD (GERD: 44.9% versus 27.8%; diabetes: 40.8% versus 31.1%; osteoporosis/osteopenia: 18.8% versus 14.1%, respectively). Compared with matched cohorts with COPD only, cohorts of COPD patients with either GERD, diabetes, or osteoporosis/osteopenia experienced increased risk of severe exacerbations (odds ratio [OR]=1.819, OR=1.119, and OR=1.373, respectively), moderate exacerbations (OR=1.699, OR=1.102, and OR=1.322, respectively), or any exacerbations (OR=1.848, OR=1.099, and OR=1.384, respectively, p<0.001 for all comparisons) and increased risk of COPD-related HCRU (emergency department visits: OR=1.983, OR=1.098, and OR=1.343, respectively; hospitalization visits: OR=2.222, OR=1.26, and OR=1.368, respectively; p<0.001 for all comparisons).

Conclusion: These real-world data confirm that GERD, diabetes, and osteoporosis are common morbidities in patients with COPD and, moreover, that they affect frequency of exacerbation and HCRU. Determining and addressing the mechanisms behind the systemic effects of COPD may be beneficial for COPD patients and may also help reduce COPD exacerbations.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
从美国数据库看慢性阻塞性肺病患者的多病症与病情恶化和医疗资源使用增加有关
背景:慢性阻塞性肺病(COPD)患者通常会发展成其他疾病,这表明该疾病具有系统性因素。这项回顾性非干预性队列研究利用 Optum 的去标识化 Clinformatics® Data Mart 数据库中的真实证据,调查了慢性阻塞性肺病多发病之间的关系及其对慢性阻塞性肺病恶化和慢性阻塞性肺病相关医疗资源利用率(HCRU)的影响:方法: 评估人口统计学和临床特征。采用描述性统计方法比较了年龄匹配的慢性阻塞性肺病队列与非慢性阻塞性肺病队列的总体合并症负担以及患有胃食管反流病 (GERD)、糖尿病或骨质疏松症/骨质疏松症的患者比例。在患有和未患有特定常见疾病(胃食管反流病、糖尿病和骨质疏松症/骨质疏松症)的年龄匹配的慢性阻塞性肺病患者队列中,对慢性阻塞性肺病恶化和慢性阻塞性肺病相关 HCRU(住院和急诊就诊)进行了比较。此外,还对患有和未患有糖尿病以及患有和未患有骨质疏松症/骨质疏松症的慢性阻塞性肺病患者进行了体重匹配。随访期为五年:患有和未患有慢性阻塞性肺病的年龄匹配队列各有 158 106 名患者。与无慢性阻塞性肺病的队列相比,慢性阻塞性肺病队列中的发病率更高(胃食管反流病:44.9% 对 27.8%;糖尿病:40.8% 对 31.1%;骨质疏松症/骨质疏松症:40.8% 对 31.1%):分别为:胃食管反流病:44.9% 对 27.8%;糖尿病:40.8% 对 31.1%;骨质疏松症/骨质疏松:18.8% 对 14.1%)。与仅患有慢性阻塞性肺病的匹配队列相比,患有胃食管反流病、糖尿病或骨质疏松症/骨质疏松症的慢性阻塞性肺病患者队列发生严重恶化(几率比 [OR] 分别为 1.819、OR=1.119 和 OR=1.373)、中度恶化(分别为 OR=1.699、OR=1.102 和 OR=1.322)或任何恶化(分别为 OR=1.848、OR=1.099 和 OR=1.384)的风险均有所增加:这些真实世界的数据证实,胃食管反流病、糖尿病和骨质疏松症是慢性阻塞性肺病患者的常见疾病,而且它们会影响病情加重的频率和 HCRU。确定并解决慢性阻塞性肺病系统性影响背后的机制可能对慢性阻塞性肺病患者有益,也可能有助于减少慢性阻塞性肺病的恶化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
期刊最新文献
A Systematic Review of Sleep Disturbance in Idiopathic Intracranial Hypertension. Advancing Patient Education in Idiopathic Intracranial Hypertension: The Promise of Large Language Models. Anti-Myelin-Associated Glycoprotein Neuropathy: Recent Developments. Approach to Managing the Initial Presentation of Multiple Sclerosis: A Worldwide Practice Survey. Association Between LACE+ Index Risk Category and 90-Day Mortality After Stroke.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1